Dr. Ravinder Kang, MD

Dr. Kang practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Kang's NPI, 1306266887, was assigned on April 23, 2014. Dr. Kang holds New Hampshire license 17766.

Dr. Kang's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Kang's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Kang is also affiliated with New London Hospital. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Kang to 1 more medical group, named with a free account. Dr. Kang's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kang practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Kang's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Kang is licensed in New Hampshire.

CMS data shows 128 Medicare services from Dr. Kang across 4 procedure codes in 2024, for 114 Medicare patients. Medicare paid $14,555 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 114 Medicare patients who saw Dr. Kang in 2024. The largest group is 65 to 74, with 50 patients. 60% of them have high blood pressure, and 56% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kang's median patient age at 64, with 53% women.

In 2024, Dr. Kang wrote 19 Medicare Part D claims. 84% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $62 in total drug cost. In 2016, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Kang for performance year 2024, reported through an alternative payment model (APM). Dr. Kang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kang as offering telehealth. CMS counts 14 procedures of melanoma (skin cancer) excision by Dr. Kang, more than 69% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 34 papers to Dr. Kang, published from 2016 to 2025. 2018 was the busiest year, with 12. The most frequent topics are Aortic Aneurysm, Abdominal, Endovascular Procedures and Melanoma. Dr. Kang has published most often in J Vasc Surg. Dr. Kang's most frequent co-authors are Philip Paul Goodney, MD, Jesse A. Columbo, MD and David H. Stone, MD.

CMS Open Payments shows 1 general payment to Dr. Kang from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $157.